Castle Biosciences (CSTL) News Today $19.41 +0.07 (+0.36%) Closing price 04:00 PM EasternExtended Trading$18.95 -0.46 (-2.36%) As of 06:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CSTL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Castle Biosciences, Inc. (NASDAQ:CSTL) Receives $37.00 Consensus Price Target from AnalystsAugust 13 at 2:05 AM | americanbankingnews.comCastle Biosciences Updates Bylaws for Improved GovernanceAugust 12 at 4:16 PM | theglobeandmail.comCastle Biosciences’ Earnings Call: Growth Amid ChallengesAugust 12 at 6:41 AM | theglobeandmail.comCastle Biosciences (NASDAQ:CSTL) Stock Rating Upgraded by Wall Street ZenAugust 12 at 2:19 AM | americanbankingnews.comCastle Biosciences (NASDAQ:CSTL) Raised to "Hold" at Wall Street ZenAugust 11 at 2:18 AM | marketbeat.comCastle Biosciences, Inc. (NASDAQ:CSTL) Given Consensus Recommendation of "Buy" by AnalystsAugust 11 at 2:15 AM | marketbeat.comXTX Topco Ltd Invests $393,000 in Castle Biosciences, Inc. (NASDAQ:CSTL)August 10 at 3:41 AM | marketbeat.comLeerink Partnrs Issues Optimistic Forecast for CSTL EarningsAugust 8, 2025 | marketbeat.comLeerink Partnrs Brokers Increase Earnings Estimates for CSTLAugust 8, 2025 | americanbankingnews.comCastle Biosciences, Inc. (NASDAQ:CSTL) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | msn.comCastle Biosciences (NASDAQ:CSTL) Shares Gap Up Following Earnings BeatAugust 7, 2025 | americanbankingnews.comCastle Biosciences (NASDAQ:CSTL) Shares Gap Up Following Strong EarningsAugust 6, 2025 | marketbeat.comCastle Biosciences (NASDAQ:CSTL) Posts Earnings Results, Beats Expectations By $0.59 EPSAugust 5, 2025 | marketbeat.comCastle Biosciences Reports Strong Q2 2025 Financial ResultsAugust 5, 2025 | msn.comCastle Biosciences raises FY25 revenue view to $310M-$320M from $287M-$297MAugust 5, 2025 | msn.comCastle Biosciences, Inc. (CSTL) Q2 2025 Earnings Call TranscriptAugust 4, 2025 | seekingalpha.comCastle (CSTL) Q2 Revenue Tops EstimatesAugust 4, 2025 | fool.comCastle Biosciences Reports Second Quarter 2025 ResultsAugust 4, 2025 | globenewswire.comCastle Biosciences (CSTL) Projected to Post Quarterly Earnings on MondayAugust 3, 2025 | americanbankingnews.comExamining the Future: Castle Biosciences's Earnings OutlookAugust 1, 2025 | benzinga.comCastle Biosciences to Present at the Canaccord Genuity 45th Annual Growth ConferenceJuly 29, 2025 | globenewswire.comCastle Biosciences (CSTL) to Release Earnings on MondayJuly 28, 2025 | marketbeat.comCastle Biosciences (NASDAQ:CSTL) shareholders have endured a 58% loss from investing in the stock five years agoJuly 27, 2025 | finance.yahoo.comCerity Partners LLC Buys Shares of 21,138 Castle Biosciences, Inc. (NASDAQ:CSTL)July 27, 2025 | marketbeat.comAllianz Asset Management GmbH Acquires 317,103 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)July 26, 2025 | marketbeat.comCastle Biosciences stock jumps after FDA grants Breakthrough Device statusJuly 25, 2025 | investing.comCastle Biosciences, Revolution Medicines get FDA breakthrough statusesJuly 25, 2025 | msn.comCastle Biosciences stock jumps after FDA grants Breakthrough Device status to melanoma testJuly 25, 2025 | msn.comCastle Biosciences’ Founder, President and CEO Derek Maetzold Named a Most Admired CEO by the Houston Business JournalJuly 25, 2025 | finance.yahoo.comCastle Biosciences' Founder, President and CEO Derek Maetzold Named a Most Admired CEO by the Houston Business JournalJuly 25, 2025 | globenewswire.comFDA Grants Breakthrough Device Designation to Castle Biosciences' DecisionDx®-Melanoma TestJuly 23, 2025 | globenewswire.comLeerink Partnrs Has Pessimistic Outlook of CSTL Q2 EarningsJuly 23, 2025 | marketbeat.comNew York State Common Retirement Fund Has $3.27 Million Stock Position in Castle Biosciences, Inc. (NASDAQ:CSTL)July 23, 2025 | marketbeat.comHussman Strategic Advisors Inc. Sells 52,500 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)July 19, 2025 | marketbeat.comCastle Biosciences (NASDAQ:CSTL) Trading Down 4% - Here's What HappenedJuly 18, 2025 | marketbeat.comJackson Creek Investment Advisors LLC Acquires New Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL)July 18, 2025 | marketbeat.comCastle Biosciences Honored with Multiple Top Workplaces Awards Recognizing the Company's Strong CultureJuly 17, 2025 | globenewswire.comCastle Biosciences, Inc. (NASDAQ:CSTL) Stock Holdings Lessened by Kornitzer Capital Management Inc. KSJuly 16, 2025 | marketbeat.comCastle Biosciences, Inc. (NASDAQ:CSTL) Receives Consensus Recommendation of "Buy" from AnalystsJuly 16, 2025 | marketbeat.comCastle Biosciences to Release Second Quarter 2025 Financial Results and Host Conference Call on Monday, Aug. 4, 2025July 14, 2025 | globenewswire.comPrincipal Financial Group Inc. Purchases 32,208 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)July 9, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Raises Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL)July 7, 2025 | marketbeat.comCastle Biosciences, Inc. (NASDAQ:CSTL) Shares Sold by Palisade Capital Management LPJuly 3, 2025 | marketbeat.comCastle Biosciences, Inc. (CSTL) - Yahoo FinanceJune 25, 2025 | finance.yahoo.comCastle Biosciences, Inc.: Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 19, 2025 | finanznachrichten.deCastle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 19, 2025 | globenewswire.comCastle Biosciences partners with SciBase for diagnostic testsJune 17, 2025 | msn.comCastle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic DiseasesJune 16, 2025 | globenewswire.comCastle Biosciences, Inc. (NASDAQ:CSTL) Shares Sold by Harbor Capital Advisors Inc.June 15, 2025 | marketbeat.comCastle Biosciences' Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International ConventionJune 11, 2025 | globenewswire.com Get Castle Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CSTL and its competitors with MarketBeat's FREE daily newsletter. Email Address CSTL Media Mentions By Week CSTL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CSTL News Sentiment▼0.870.71▲Average Medical News Sentiment CSTL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CSTL Articles This Week▼155▲CSTL Articles Average Week Get Castle Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CSTL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Veracyte News Addus HomeCare News Progyny News Celcuity News Ardent Health News LifeStance Health Group News PACS Group News National HealthCare News Viridian Therapeutics News Aveanna Healthcare News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CSTL) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Castle Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Castle Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access